The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Pharmaceuticals

To order this detailed 600+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-08-27 15:00.

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

Pharmaceuticals

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and ... Read more

Submitted by Roots_Analysis on 2020-08-27 14:59.

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the ... Read more

Submitted by Roots_Analysis on 2020-08-27 14:57.

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

Submitted by Roots_Analysis on 2020-08-27 14:56.

The “Gene Therapy Market (3rd Edition), 2019-2030” report

Market-Research

Key Inclusions

A detailed review of the overall landscape of gene therapies and genome editing therapies, including information on various drug / therapy developer companies, phase of development (marketed, clinical, and preclinical / discovery stage) of pipeline

Submitted by Roots_Analysis on 2020-08-27 08:56.

Presently, there are more than 10 approved gene therapies; over 465 product

Market-Research

Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their efforts on the development of novel gene editing therapies. In fact, the gene therapy pipeline has evolved significantly over the past few ... Read more

Submitted by Roots_Analysis on 2020-08-27 08:52.

The gene therapy market is projected to grow at an annualized rate of 45%, till 2030

Market-Research

Roots Analysis has done a detailed study on Gene Therapy Market (3rd Edition), 2019-2030, covering ... Read more

Submitted by Roots_Analysis on 2020-08-27 08:48.

The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of ADCs, providing information on drug developer(s) and technology provider(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target antigen,

Submitted by Roots_Analysis on 2020-08-27 08:43.

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors

Market-Research

Submitted by Roots_Analysis on 2020-08-27 08:36.

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

Market-Research

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the ... Read more

Submitted by Roots_Analysis on 2020-08-27 08:30.

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030

Market-Research

Submitted by Roots_Analysis on 2020-08-27 08:25.

The “Global Collaborative Robots (Cobots) Market, 2020-2030” report features an extensive study of the potential applications, current landscape and the likely adoption of cobots across various industrial applications, over the next decade.

Pharmaceuticals

To order this detailed 245+ page report, please visit this link

Key Inclusions

An overview of the current market landscape of

Submitted by Roots_Analysis on 2020-08-26 11:36.

Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being actively adopted across various industries, including the life sciences and pharmaceutical industry, claims Roots Analysis

Pharmaceuticals

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:34.

The global collaborative robots (cobots) market is projected to grow at an annualized rate of 34.4%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030, covering key aspects of the industry’s evolution and identifying ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:33.

The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, growing at a CAGR of 34.4%, claims Roots Analysis

Pharmaceuticals

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation

Submitted by Roots_Analysis on 2020-08-26 11:31.

Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices

Pharmaceuticals

To order this 540+ page report, please visit this link

Key ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:17.

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Pharmaceuticals

The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:16.

The large volume wearable injectors market is projected to grow at an annualized rate of ~35%, till 2030

Fitness

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:13.

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

Fitness

Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries; in fact, these ... Read more

Submitted by Roots_Analysis on 2020-08-26 11:10.

The “Large Volume Wearable Injectors Market (5th Edition), 2020-2030

Market-Research

Key Inclusions

An overview of current market landscape of the large volume wearable injectors available for delivery of insulin and non-insulin drugs, providing information on status of development and device specifications, such as type of device (patch pump /

Submitted by Roots_Analysis on 2020-08-26 08:21.

Pages